Clinical Trial Update: Study to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Psoriasis Treated With Subcutaneous Risankizumab Injection According to Standard of Care

View source ↗

Summary

This clinical trial update indicates a study evaluating change in psoriasis symptoms in adults with moderate to severe psoriasis treated with subcutaneous risan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• SKYRIZI (risankizumab-rzaa)

Snippet

Sponsor: AbbVie | Conditions: Psoriasis | Status: ACTIVE_NOT_RECRUITING